“Helmholtz makes important contributions to solve the Corona crisis.”

The number of SARS-CoV-2 infections is increasing dramatically from day to day in Germany and worldwide. Researchers at the Helmholtz Centers are working on the development of new active substances, antibody therapies and testing procedures, the deciphering of infection mechanisms and epidemiological questions. In more than 20 research projects – mainly in the Research Field Read more about “Helmholtz makes important contributions to solve the Corona crisis.”[…]

New, cost-effective process for series production of lightweight vehicle components

Very light, structurally stable components made of thermoset fiber composites have been used for many years in motor sports and in the field of high-quality sports vehicles. Carbon components (carbon-fiber-reinforced plastics, CFRPs) such as roof modules can be efficiently produced using the so-called resin transfer molding (RTM) process. In order to reduce costs and use Read more about New, cost-effective process for series production of lightweight vehicle components[…]

imec and Park Systems sign the 2nd JDP to Increase the Strategic Investment in Developing Nano-Metrology Solutions for Semiconductor Manufacturing

Park Systems, the global leader and innovator of Atomic Force Microscopy and Metrology solutions, and imec, world-leading R&D and innovation hub in nanoelectronics and digital technologies, have signed the 2nd Joint Development Project (JDP) within 4 years to increase the development efforts for future generation in-line AFM metrology solutions. The official signing ceremony has taken Read more about imec and Park Systems sign the 2nd JDP to Increase the Strategic Investment in Developing Nano-Metrology Solutions for Semiconductor Manufacturing[…]

Beak started development of the Saxon Dimension Stone Cadastre

At the end of January 2020, Beak Consultants GmbH was awarded with a project from the Saxon Mining Authority to develop the Saxon Dimension Stone Cadastre. Saxony’s raw materials strategy views the update of the existing raw material databases as a basis for supporting the profitable mining of domestic raw materials by the commercial economic Read more about Beak started development of the Saxon Dimension Stone Cadastre[…]

Kuros strengthens orthobiologics patent portfolio

Grant of US patent covering the use of PTH containing matrices for spinal fusion Grant of US patent covering osteoinductive materials made by certain methods Further strengthens Kuros’s position as a leader in the field of orthobiologics Kuros Biosciences (SIX: KURN) today announced that its subsidiary, Kuros Biosurgery AG, has been granted the US patent, Read more about Kuros strengthens orthobiologics patent portfolio[…]

QIAGEN dramatically ramping up global production capacity for RNA extraction kits for use in detection of SARS-CoV-2 coronavirus

Goal to reach global capacity for RNA nucleic extraction workflows for over 10 million patient tests a month by end of June 2020 and to reach capacity for 20 million monthly patient tests by end of 2020 Welcomes FDA and CDC expansion of QIAGEN kits and instruments that can be used for RNA nucleic extraction Read more about QIAGEN dramatically ramping up global production capacity for RNA extraction kits for use in detection of SARS-CoV-2 coronavirus[…]

Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies

Upon successful completion of the business combination, Immatics will receive up to approximately $148 million of cash held within Arya’s trust account Leading institutional investors commit $104 million of cash through a common stock private investment in public equity (“PIPE”) led by Perceptive Advisors and other top-tier US healthcare investors Immatics shareholders, Arya shareholders and PIPE Read more about Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies[…]

Immunic, Inc. Reports Year End 2019 Financial Results and Highlights Recent Achievements

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced financial results for the year ended December 31, 2019 and highlighted recent achievements. "In addition to the closing of our stock-for-stock exchange transaction with Vital Therapies, Inc., which provided our Nasdaq Read more about Immunic, Inc. Reports Year End 2019 Financial Results and Highlights Recent Achievements[…]

QIAGEN gains BARDA funding for approval process of QIAstat-Dx test kit for SARS-CoV-2 coronavirus

  First syndromic testing solution to get U.S. agency’s development support in novel coronavirus response QIAstat-Dx Respiratory SARS-CoV-2 Panel test kit will rapidly differentiate novel coronavirus from 21 other pathogens implicated in respiratory syndromes Further expanding QIAGEN’s global mobilization to scale up testing supplies for the COVID-19 response QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) Read more about QIAGEN gains BARDA funding for approval process of QIAstat-Dx test kit for SARS-CoV-2 coronavirus[…]

IBM and Fraunhofer bring Quantum Computing to Germany

The Fraunhofer-Gesellschaft, Europe’s leading organization for applied research, and IBM (NYSE: IBM) announced today the signing of the agreement aimed at advancing quantum computing in Germany. The collaboration gives companies and research institutions access to IBM quantum computers in Germany and the USA under the umbrella of a nationwide Fraunhofer competence network. The aim is Read more about IBM and Fraunhofer bring Quantum Computing to Germany[…]